Marijn E. Dekkers

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Boston, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Mark Bodenrader, as Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Marijn E. Dekkers

Form 4 holding Director

Ginkgo Bioworks Holdings, Inc.

Security class
Class A Common Stock
Shares / value
5,515,364
Estimated value
$3,027,935
Report date
12 Jun 2024
Price
$0.5490
Ownership
By Novalis LifeSciences Investments I, L.P.
Form 4 holding Director

Quanterix Corp

Security class
Common Stock
Shares / value
2,270
Estimated value
$61,086
Report date
07 Jun 2021
Price
$26.91
Ownership
Direct
Form 4 holding Director

Ginkgo Bioworks Holdings, Inc.

Security class
Restricted Stock Units
Shares / value
0
Estimated value
$0
Report date
12 Jun 2024
Price
$0.5490
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
Form 4 holding Director

Ginkgo Bioworks Holdings, Inc.

Security class
Stock Option
Shares / value
139,860
Estimated value
Report date
16 Jun 2023
Price
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
Form 4 holding Director

Quantum-Si Inc

Security class
Stock Option (right to buy)
Shares / value
59,880
Estimated value
Report date
11 May 2022
Price
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
Form 4 holding Director

Cerevel Therapeutics Holdings, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
01 Aug 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Quanterix Corp

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
07 Jun 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Marijn E. Dekkers

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .